NR2F1 and breast cancer: Consistently, our data also displayed that EBF1 overexpression reversed inhibitory effects of sh-LINC00663 on inflammation and vascular mimicry in BC cells, and further animal experiments showed that silencing LINC00663 decreased NR2F1 expression by binding EBF1, thereby repressing BC inflammation and angiogenesis.